NRX Pharmaceuticals Inc. Common Stock
Exchange: NASDAQ
Symbol: NRXP
SEC CIK: 0001719406
Phone: 484-254-6134
1201 N. MARKET STREET
SUITE 111
WILMINGTON DE 19801
CEO:
|
Price when page updated: 0.334 Date: 2023-12-01
Company Website:
www.bigrockpartners.com/spac/spac_aboutus.html
|
_Description: Big Rock Partners is a blank check company formed for the purpose of entering into a merger, stock exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. Big Rock Partners' management team includes Richard Ackerman, Chairman, President, and Chief Executive Officer, and Bennett Kim, Chief Financial Officer, Chief Investment Officer, Corporate Secretary and Director.
IPO YEAR:
2017
|
Sector:
Health Care
|
Industry:
Biotechnology: Pharmaceutical Preparations
|
ADRTSO:
|
MarketCap:
28029131.00
|
Beta:
|
52 Week High:
64.2
|
52 Week Low:
4.07
|
52 Week Change:
-0.8597325408618128
|
Short Interest:
|
Short Date:
|
Shares Outstanding:
58810338
|
Dividend Rate:
0
|
Dividend Yield:
8.13%
|
ExDividend Date:
|
Latest EPS:
|
Latest EPS Date:
27 Oct 2022
|
Float:
0
|
return on Equity:
-99.00%
|
Consensus EPS:
|
Number Of Estimates:
|
EPS Surprise Dollar:
|
Eps Surprise Percent:
|
EBITDA:
$4.564B
|
ttmEPS:
0
|
Revenue:
$25.476B
|
Gross Profit:
|
Cash:
|
Debt:
|
Institution Percent:
60.20%
|
Revenue Percent:
|
Revenue Per Employee:
|
Insider Percent:
0.07%
|
Return on Assets:
4.50%
|
Return on Capital:
|
Profit Margin:
6.80%
|
Price to Sales:
3.26
|
Price To Book:
-
|
Short Ratio:
2.17
|
PE Ratio:
0
|
Employees:
2
|
1Y Guesstimate
N/A:N/A:N/A
|
|
|
|
|
|
|
|
|
__The following are links to various summary and news pages for
__NRX Pharmaceuticals Inc. Common Stock [ NRXP ].
__Note: Some Links might not have information for the company.
|
|
